IS3788A7 - Methods for the preparation of solid dosage forms containing almokalant - Google Patents

Methods for the preparation of solid dosage forms containing almokalant

Info

Publication number
IS3788A7
IS3788A7 IS3788A IS3788A IS3788A7 IS 3788 A7 IS3788 A7 IS 3788A7 IS 3788 A IS3788 A IS 3788A IS 3788 A IS3788 A IS 3788A IS 3788 A7 IS3788 A7 IS 3788A7
Authority
IS
Iceland
Prior art keywords
almokalant
preparation
methods
dosage forms
solid dosage
Prior art date
Application number
IS3788A
Other languages
Icelandic (is)
Inventor
Hjalmar Andersson Kjell
Johan Gunnar Lundberg Per
Roger Simonsson Leif
Helena Johansson Karin
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of IS3788A7 publication Critical patent/IS3788A7/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS3788A 1990-12-07 1991-12-06 Methods for the preparation of solid dosage forms containing almokalant IS3788A7 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (en) 1990-12-07 1990-12-07 SOLID DOSAGE FORMS OF A DRUG

Publications (1)

Publication Number Publication Date
IS3788A7 true IS3788A7 (en) 1992-06-08

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
IS3788A IS3788A7 (en) 1990-12-07 1991-12-06 Methods for the preparation of solid dosage forms containing almokalant

Country Status (27)

Country Link
EP (1) EP0560821A1 (en)
JP (1) JPH06503312A (en)
CN (1) CN1063039A (en)
AP (1) AP258A (en)
AU (1) AU8930791A (en)
BG (1) BG97851A (en)
CA (1) CA2097178A1 (en)
CZ (1) CZ103793A3 (en)
FI (1) FI932554L (en)
HU (1) HUT64217A (en)
IE (1) IE914137A1 (en)
IL (1) IL100150A0 (en)
IS (1) IS3788A7 (en)
LT (1) LTIP1717A (en)
MA (1) MA22355A1 (en)
MX (1) MX9102325A (en)
MY (1) MY106776A (en)
NO (1) NO932052L (en)
NZ (1) NZ240731A (en)
PT (1) PT99719A (en)
SE (1) SE9003902D0 (en)
SK (1) SK55693A3 (en)
TN (1) TNSN91117A1 (en)
TW (1) TW215057B (en)
WO (1) WO1992010172A1 (en)
YU (1) YU186891A (en)
ZA (1) ZA919264B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (en) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Solid instant release dosage forms and processes for their manufacture
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (en) * 1998-07-30 2010-07-14 佐藤製薬株式会社 Orally disintegrating tablets
JP7426685B2 (en) * 2018-06-14 2024-02-02 株式会社東洋新薬 tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (en) * 1987-12-23 1987-12-23 Haessle Ab NOVEL ANTIARRHYTHMIC AGENTS
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE

Also Published As

Publication number Publication date
BG97851A (en) 1994-04-29
JPH06503312A (en) 1994-04-14
LTIP1717A (en) 1995-07-25
HU9301670D0 (en) 1993-09-28
PT99719A (en) 1992-10-30
CN1063039A (en) 1992-07-29
NO932052D0 (en) 1993-06-04
CZ103793A3 (en) 1994-02-16
WO1992010172A1 (en) 1992-06-25
IL100150A0 (en) 1992-08-18
ZA919264B (en) 1992-08-26
TW215057B (en) 1993-10-21
EP0560821A1 (en) 1993-09-22
AU8930791A (en) 1992-07-08
SK55693A3 (en) 1993-10-06
NO932052L (en) 1993-06-04
CA2097178A1 (en) 1992-06-08
HUT64217A (en) 1993-12-28
SE9003902D0 (en) 1990-12-07
TNSN91117A1 (en) 1992-10-25
MX9102325A (en) 1992-06-01
MA22355A1 (en) 1992-07-01
FI932554A7 (en) 1993-06-08
MY106776A (en) 1995-07-31
NZ240731A (en) 1993-10-26
AP258A (en) 1993-06-03
AP9100338A0 (en) 1992-01-31
FI932554L (en) 1993-06-08
IE914137A1 (en) 1992-06-17
YU186891A (en) 1994-04-05

Similar Documents

Publication Publication Date Title
FI905124A0 (en) Method for the preparation of pyrimidines
FI914174A7 (en) Process for the preparation of piperidylalkylamines
FI903429A0 (en) COMPOUND COMPOSITION OF PEPTIDER MED FOERDROEJD FRIGOERING.
NO914429L (en) PROCEDURE FOR THE PREPARATION OF PIPERIDINYL CAMPERSULPHONYLOXYTOCIN ANTAGONISTS
FI92403B (en) Method for the preparation of cefodizim disodium
FI95036B (en) Method for the preparation of thieno-triazolo-diazepine derivatives
NO834729L (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE TIO-CEPHALOSPORINES
ES536795A0 (en) PROCEDURE FOR THE PREPARATION OF NONAPEPTIDES AND DODECAPEPTIDES
FI890186A7 (en) Process for the preparation of 1-hydroxyalkyl-5-nitroimidazoles
NO301716B1 (en) Process for the preparation of calcium L-ascorbate-2-phosphate
ES2013216A4 (en) PROCESS FOR THE PREPARATION OF N - PHOSPHONOMETILGLICINA
EE03027B1 (en) Process for the preparation of 8-chloroquinolone derivatives
FI904570A7 (en) Method for the preparation of new alkanophenones I
FI890188A7 (en) Process for the preparation of 1-hydroxyalkyl-2-methyl-5-nitroimidazoles
FI913464A7 (en) Process for the preparation of 1-hydroxymethylpyrazoles
FI892144A7 (en) Method for the preparation of 5-C-hydroxymethylaldohexose-based compounds
FI902590A7 (en) Process for the preparation of 2-oxoindole-1-carboxamides
IT8822524A0 (en) PROCEDURE FOR THE PREPARATION OF 6-OXOPENICILLANATES
IL100150A0 (en) Solid dosage forms of almokalant and processes for manufacture thereof
FI940338L (en) Process for the preparation of 13alpha-cinnamoylbaccatin III or -10-deacetylbaccatin III
NO901422D0 (en) PROCEDURE FOR THE PREPARATION OF ALFA-GLUCOSIDASE INHIBITORS.
FI911126A0 (en) Organocuprate method for the preparation of cefprozil
BR8706857A (en) PROCESSES FOR THE PREPARATION OF MALEIMIDAL COMPOUNDS, THERMOSTENDABLE COMPOUNDS AND WITHOUT THE USE OF AN ORGANOSILIC COMPOUND
FI93363C (en) New process for the preparation of 2-diazo-3-trisubstituted silyloxy-3-butenoates
FI913656A7 (en) Process for the preparation of alkyl-6-pyridazine derivatives